Seqens Seqens

X

Find Radio Compass News for MolPort-001-792-504

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
249
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 25MG
  • TABLET;ORAL - 50MG
  • TABLET;ORAL - 75MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

https://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-launch-of-aspirin-and-extended-release-dipyridamole-capsules-25mg200mg-300929488.html

PR NEWSWIRE
03 Oct 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-21-2019-1566366765.pdf

FDA
21 Aug 2019

https://www.prnewswire.com/news-releases/lannett-launches-aspirin-and-extended-release-dipyridamole-capsules-300869795.html

PR NEWSWIRE
19 Jun 2019

https://www.thehindubusinessline.com/companies/glenmark-pharma-gets-usfda-nod-for-antiplatelet-drug/article27259993.ece

THEHINDUBUSINESSLINE
28 May 2019

https://www.prnewswire.com/news-releases/lannett-receives-fda-approval-for-aspirin-and-extended-release-dipyridamole-capsules-25-mg200-mg-300819106.html

PR NEWSWIRE
27 Mar 2019

https://www.biospectrumasia.com/news/33/12377/dr-reddys-launches-aspirin-and-extended-release-dipyridamole-capsules-in-usa.html

BIOSPECTRUM
27 Dec 2018

https://www.thepharmaletter.com/in-brief/brief-ftc-imposes-conditions-on-amneal-acquisition-of-impax

PHARMA LETTER
11 Jul 2018

https://www.ftc.gov/news-events/press-releases/2018/07/ftc-approves-final-order-imposing-conditions-merger-generic-drug

FTC GOV
11 Jul 2018

https://www.prnewswire.com/news-releases/ani-pharmaceuticals-completes-acquisition-of-generic-products-and-assets-from-amnealimpax-300642867.html

PR NEWSWIRE
07 May 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206753

FDA
31 Aug 2017

http://www.reuters.com/article/usa-court-ftc-boehringer-idUSL2N14Y2Z7

Diane Bartz REUTERS
20 Jan 2016

http://www.pharmabiz.com/NewsDetails.aspx?aid=89219&sid=2

PHARMABIZ
02 Jul 2015

http://www.fiercepharmaasia.com/story/idt-australia-release-fda-nod-23-generics-begs-question-wheres-beef/2015-04-14

EJ Lane FIERCE PHARMA ASIA
14 Apr 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY